Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience.
Giammarco S, Maggi R, Di Marino L, Chiusolo P, Teofili L, Piccirilo N, Metafuni E, Limongiello MA, Leotta S, Milone G, Cupri A, Cutini I, Saccardi R, Nozzoli C, Boncompagni R, Gozzini A, Scappini B, Piccini M, Fracchiolla NS, Sica S. Giammarco S, et al. Among authors: metafuni e. Bone Marrow Transplant. 2024 Nov 21. doi: 10.1038/s41409-024-02475-0. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39567768 No abstract available.
Posttransplant Autoimmune Hemolytic Anemia with Anti-D Specificity Successfully Treated with Daratumumab: A Case Report.
Frioni F, Metafuni E, Limongiello MA, Piccirillo N, Massini G, Pellegrino C, Giammarco S, Sorà F, Autore F, Teofili L, Sica S, Chiusolo P. Frioni F, et al. Among authors: metafuni e. Transfus Med Hemother. 2024 Mar 19;51(5):355-358. doi: 10.1159/000535927. eCollection 2024 Oct. Transfus Med Hemother. 2024. PMID: 39371256 Free PMC article.
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.
Secondino S, Badoglio M, Rosti G, Labopin M, Delaye M, Bokemeyer C, Seidel C, Kanfer E, Metafuni E, Finke J, Bouhris JH, Kosmas C, Malard F, Pagani A, Kuball J, Koehl U, Ruggeri A, De Giorgi U, Pedrazzoli P; EBMT Cellular Therapy & Immunobiology WP. Secondino S, et al. Among authors: metafuni e. ESMO Open. 2024 Sep;9(9):103692. doi: 10.1016/j.esmoop.2024.103692. Epub 2024 Sep 5. ESMO Open. 2024. PMID: 39241498 Free PMC article.
The impact of donor-specific antibodies' presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center.
Sica S, Metafuni E, Frioni F, Limongiello MA, Galli E, Sorà F, Bacigalupo A, Poggi E, Feccia MA, Manfreda A, Chiusolo P, Giammarco S. Sica S, et al. Among authors: metafuni e. Front Oncol. 2024 Aug 21;14:1387181. doi: 10.3389/fonc.2024.1387181. eCollection 2024. Front Oncol. 2024. PMID: 39234400 Free PMC article.
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, Palazzi R, Paulicelli J, Mariotti D, Mazzotta V, Notari S, Casetti R, Francalancia M, Rosati S, D'Abramo A, Mija C, Mencarini P, Milozzi E, Caraffa E, Sica S, Metafuni E, Sorà F, Rago A, Siniscalchi A, Abruzzese E, Garzia M, Luzi G, Battistini R, Prosperini L, Cingolani A, Girardi E, Maggi F, Antinori A; OCTOPUS Study Group. Vergori A, et al. Among authors: metafuni e. Vaccines (Basel). 2024 Jul 17;12(7):784. doi: 10.3390/vaccines12070784. Vaccines (Basel). 2024. PMID: 39066422 Free PMC article.
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.
Spanjaart AM, Ljungman P, Tridello G, Schwartz J, Martinez-Cibrián N, Barba P, Kwon M, Lopez-Corral L, Martinez-Lopez J, Ferra C, Di Blasi R, Ghesquieres H, Mutsaers P, Calkoen F, Jak M, van Doesum J, Vermaat JSP, van der Poel M, Maertens J, Gambella M, Metafuni E, Ciceri F, Saccardi R, Nicholson E, Tholouli E, Matthew C, Potter V, Bloor A, Besley C, Roddie C, Wilson K, Nagler A, Campos A, Petersen SL, Folber F, Bader P, Finke J, Kroger N, Knelange N, de La Camara R, Kersten MJ, Mielke S. Spanjaart AM, et al. Among authors: metafuni e. Leukemia. 2024 Sep;38(9):1985-1991. doi: 10.1038/s41375-024-02336-1. Epub 2024 Jul 23. Leukemia. 2024. PMID: 39043963 Free PMC article.
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review.
Metafuni E, Busnego Barreto MT, Valentini CG, Giammarco S, Limongiello MA, Sorà F, Bianchi M, Massini G, Piccirillo N, Putzulu R, Frioni F, Bacigalupo A, Teofili L, Chiusolo P, Sica S. Metafuni E, et al. Front Oncol. 2024 Jul 2;14:1386670. doi: 10.3389/fonc.2024.1386670. eCollection 2024. Front Oncol. 2024. PMID: 39015495 Free PMC article.
89 results